STOCK TITAN

[Form 4] Cerence Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Cerence Inc. (CRNC) reported an insider transaction by EVP and Chief Revenue Officer Christian Mentz showing a mandatory sale of 26,872 shares on 10/06/2025 at a reported price of $12.7573 per share to satisfy tax-withholding on vested restricted stock units (RSUs). After the transaction the reporting person beneficially owned 111,875 shares, reported as disposed for Form 4 purposes. The Form 4 clarifies this was a company‑mandated "sell to cover" to cover tax obligations and is described as not a discretionary trade by the reporting person. The filing was signed by an attorney-in-fact on 10/07/2025.

Cerence Inc. (CRNC) ha riportato una transazione interna da parte dell'EVP e Chief Revenue Officer Christian Mentz che mostra una vendita obbligatoria di 26.872 azioni il 10/06/2025 a un prezzo riportato di $12.7573 per azione per soddisfare la ritenuta fiscale sulle unità azionarie soggette a vesting (RSU). Dopo la transazione la persona che segnala possedeva beneficiariamente 111.875 azioni, riportate come cedute ai fini del Modulo 4. Il Modulo 4 chiarisce che si è trattato di una vendita imposta dall'azienda per coprire le obbligazioni fiscali e viene descritta come non una operazione discrezionale da parte della persona che segnala. La documentazione è stata firmata da un procuratore il 10/07/2025.

Cerence Inc. (CRNC) informó una transacción interna por parte del EVP y Director de Ingresos Christian Mentz, que muestra una venta obligatoria de 26.872 acciones el 10/06/2025 a un precio reportado de $12.7573 por acción para satisfacer la retención de impuestos sobre las unidades de acciones restringidas vestidas (RSU). Después de la operación, la persona que reporta poseía de manera beneficiosa 111.875 acciones, reportadas como cedidas para fines del Formulario 4. El Formulario 4 aclara que se trató de una venta impuesta por la empresa para cubrir las obligaciones fiscales y se describe como no una operación discrecional por parte de la persona que reporta. La presentación fue firmada por un apoderado en 10/07/2025.

Cerence Inc. (CRNC)는 EVP 겸 최고매출책임자(CRO) Christian Mentz의 내부 거래를 보고했으며, 세금 원천징수를 충당하기 위한 26,872 주의 의무적 매도를 10/06/2025$12.7573의 보고된 주가로 표시했습니다. 거래 후 보고자는 혜택상 111,875 주를 소유하게 되었으며, Form 4 목적상 처분으로 보고되었습니다. Form 4는 이는 회사가 강제로 실시한 'Sell to Cover'로 세금 의무를 충당하기 위한 것이며, 보고자의 재량 거래가 아니라고 설명합니다. 제출은 10/07/2025에 대리인에 의해 서명되었습니다.

Cerence Inc. (CRNC) a rapporté une opération interne impliquant l'EVP et le Directeur des Revenus Christian Mentz, montrant une vente obligatoire de 26 872 actions le 10/06/2025 à un prix déclaré de $12,7573 par action pour satisfaire la retenue d'impôt sur les unités d'actions restreintes attribuées (RSU vesting). Après l'opération, la personne déclarant détenait avantageusement 111 875 actions, déclarées comme cédées aux fins du Formulaire 4. Le Formulaire 4 précise qu'il s'agissait d'une vente imposée par l'entreprise pour couvrir les obligations fiscales et est décrite comme non lucrative par la personne déclarante. Le dossier a été signé par un mandataire le 10/07/2025.

Cerence Inc. (CRNC) meldete eine Insider-Transaktion des EVP und Chief Revenue Officer Christian Mentz, die einen obligatorischen Verkauf von 26.872 Aktien am 10/06/2025 zu einem gemeldeten Preis von $12.7573 pro Aktie zur Begleichung der Steuerabzüge auf vesting Restricted Stock Units (RSUs) zeigt. Nach der Transaktion hielt die meldende Person vorteilhaft 111.875 Aktien, die gemäß Form 4 als veräußert gemeldet wurden. Das Formular 4 erläutert, dass es sich um einen unternehmensseitig vorgeschriebenen „Sell to Cover“ handelt, um Steuerverpflichtungen zu decken, und wird als keine diskretionäre Transaktion durch die meldende Person beschrieben. Die Einreichung wurde von einem Bevollmächtigten am 10/07/2025 unterzeichnet.

Cerence Inc. (CRNC) أبلغت عن صفقة داخلية من قِبل نائب الرئيس التنفيذي وكبير مسؤولي الإيرادات Christian Mentz تُظهر بيعًا إلزاميًا لـ 26,872 سهمًا في 10/06/2025 بسعر مُبلغ عنه قدره $12.7573 للسهم واحد لتلبية اقتطاع الضرائب على وحدات الأسهم المقيدة المحقة (RSUs). بعد الصفقة امتلك الشخص المبلغ عنه فائدة باستحقاق قدرها 111,875 سهمًا، مُبلغ عنها كتصرفات مُعلَن عنها لأغراض Form 4. يوضح Form 4 أن ذلك كان بيعًا مفروضًا من الشركة لتغطية الالتزامات الضريبية ويُوصف بأنه ليس تداولاً تقديريًا من قِبل الشخص المبلغ عنه. تم توقيع الملف من قبل وكيل قانوني في 10/07/2025.

Cerence Inc. (CRNC) 报告了一项由执行副总裁兼首席收入官 Christian Mentz 参与的内部交易,显示在 10/06/202526,872 股进行的强制出售,成交价格为每股 $12.7573,用于支付已归属的受限股票单位(RSU)的税款扣缴。在交易后,申报人实际拥有 111,875 股,按 Form 4 要求报告为处置。Form 4 说明这是公司强制的“卖出以覆盖(sell to cover)”以抵扣税款义务,并被描述为非申报人自由裁量的交易。该 filing 由代理人于 10/07/2025 签署。

Positive
  • Sell-to-cover transaction explicitly identified as non‑discretionary, indicating routine tax withholding
  • Full post-transaction beneficial ownership disclosed (111,875 shares), maintaining transparency
Negative
  • None.

Insights

Mandatory sell-to-cover for RSU taxes; not a discretionary exit.

The reported sale of 26,872 shares is identified as a company-mandated sell-to-cover to fund tax withholding tied to vested RSUs, which is a routine administrative step under equity incentive plans. This means the transaction reflects compensation settlement mechanics rather than an independent decision to liquidate holdings.

The main dependency is plan design: if the issuer continues requiring sell-to-cover, similar filings will recur around vesting dates. Watch upcoming vesting schedules and total post-transaction beneficial ownership for any change in alignment with shareholder interests over the next 6–12 months.

Sale amount aligns with tax withholding on vested RSUs; price and shares disclosed.

The Form 4 reports the share count sold (26,872) and the per-share proceeds ($12.7573), which allows simple reconciliation of the fiscal impact of withholding on the vesting event. The filing states the sale is mandated by the issuer's election in its equity plans.

Risks are limited to dilution and timing of future vesting events; monitor aggregate outstanding RSUs and any discretionary sales by insiders in the following 12 months to see if selling behavior exceeds routine withholding patterns.

Cerence Inc. (CRNC) ha riportato una transazione interna da parte dell'EVP e Chief Revenue Officer Christian Mentz che mostra una vendita obbligatoria di 26.872 azioni il 10/06/2025 a un prezzo riportato di $12.7573 per azione per soddisfare la ritenuta fiscale sulle unità azionarie soggette a vesting (RSU). Dopo la transazione la persona che segnala possedeva beneficiariamente 111.875 azioni, riportate come cedute ai fini del Modulo 4. Il Modulo 4 chiarisce che si è trattato di una vendita imposta dall'azienda per coprire le obbligazioni fiscali e viene descritta come non una operazione discrezionale da parte della persona che segnala. La documentazione è stata firmata da un procuratore il 10/07/2025.

Cerence Inc. (CRNC) informó una transacción interna por parte del EVP y Director de Ingresos Christian Mentz, que muestra una venta obligatoria de 26.872 acciones el 10/06/2025 a un precio reportado de $12.7573 por acción para satisfacer la retención de impuestos sobre las unidades de acciones restringidas vestidas (RSU). Después de la operación, la persona que reporta poseía de manera beneficiosa 111.875 acciones, reportadas como cedidas para fines del Formulario 4. El Formulario 4 aclara que se trató de una venta impuesta por la empresa para cubrir las obligaciones fiscales y se describe como no una operación discrecional por parte de la persona que reporta. La presentación fue firmada por un apoderado en 10/07/2025.

Cerence Inc. (CRNC)는 EVP 겸 최고매출책임자(CRO) Christian Mentz의 내부 거래를 보고했으며, 세금 원천징수를 충당하기 위한 26,872 주의 의무적 매도를 10/06/2025$12.7573의 보고된 주가로 표시했습니다. 거래 후 보고자는 혜택상 111,875 주를 소유하게 되었으며, Form 4 목적상 처분으로 보고되었습니다. Form 4는 이는 회사가 강제로 실시한 'Sell to Cover'로 세금 의무를 충당하기 위한 것이며, 보고자의 재량 거래가 아니라고 설명합니다. 제출은 10/07/2025에 대리인에 의해 서명되었습니다.

Cerence Inc. (CRNC) a rapporté une opération interne impliquant l'EVP et le Directeur des Revenus Christian Mentz, montrant une vente obligatoire de 26 872 actions le 10/06/2025 à un prix déclaré de $12,7573 par action pour satisfaire la retenue d'impôt sur les unités d'actions restreintes attribuées (RSU vesting). Après l'opération, la personne déclarant détenait avantageusement 111 875 actions, déclarées comme cédées aux fins du Formulaire 4. Le Formulaire 4 précise qu'il s'agissait d'une vente imposée par l'entreprise pour couvrir les obligations fiscales et est décrite comme non lucrative par la personne déclarante. Le dossier a été signé par un mandataire le 10/07/2025.

Cerence Inc. (CRNC) meldete eine Insider-Transaktion des EVP und Chief Revenue Officer Christian Mentz, die einen obligatorischen Verkauf von 26.872 Aktien am 10/06/2025 zu einem gemeldeten Preis von $12.7573 pro Aktie zur Begleichung der Steuerabzüge auf vesting Restricted Stock Units (RSUs) zeigt. Nach der Transaktion hielt die meldende Person vorteilhaft 111.875 Aktien, die gemäß Form 4 als veräußert gemeldet wurden. Das Formular 4 erläutert, dass es sich um einen unternehmensseitig vorgeschriebenen „Sell to Cover“ handelt, um Steuerverpflichtungen zu decken, und wird als keine diskretionäre Transaktion durch die meldende Person beschrieben. Die Einreichung wurde von einem Bevollmächtigten am 10/07/2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mentz Christian

(Last) (First) (Middle)
25 MALL ROAD
SUITE 416

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Revenue Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 10/06/2025 S 26,872 D $12.7573 111,875 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Remarks:
/s/ Jennifer Salinas, Attorney-in-Fact 10/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Cerence (CRNC) Form 4 filed on 10/07/2025 report?

It reported a mandatory sale of 26,872 shares by EVP/Chief Revenue Officer Christian Mentz on 10/06/2025 at $12.7573 per share to satisfy tax withholding from vested RSUs.

Was the insider sale by Christian Mentz a discretionary trade?

No. The filing states the sale was required by the issuer's equity incentive plans as a sell-to-cover to satisfy tax withholding and not a discretionary trade.

How many Cerence shares did the reporting person own after the transaction?

The Form 4 shows beneficial ownership of 111,875 shares following the reported transaction.

What price was reported for the shares sold in the Cerence Form 4?

The reported sale price was $12.7573 per share for the 26,872 shares sold on 10/06/2025.

Who signed the Form 4 for this transaction?

The filing was signed by an attorney-in-fact, Jennifer Salinas, on 10/07/2025.
Cerence Inc

NASDAQ:CRNC

CRNC Rankings

CRNC Latest News

CRNC Latest SEC Filings

CRNC Stock Data

505.54M
40.01M
7.47%
71.94%
18.31%
Software - Application
Services-prepackaged Software
Link
United States
BURLINGTON